Is Immunotherapy Appropriate Here?Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
Drs. Geoff Oxnard and Lauren Ritterhouse discuss PD-1/PD-L1 as a routine biomarker test run on all lung cancer biopsy specimens, as well as on other selected cancer types, and how qualitative and quantitative results are typically reported.
Ken Schaecher, MD, presents his own personal opinion on the multiple barriers to affordable high quality care for cancer patients. Supported through funding from Incyte